Apricus Wealth’s Relmada Therapeutics RLMD Stock Holding History

Apricus Wealth’s Portfolio RLMD Stock Details RLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$179K	Hold	47,462	–	–	0.08%	128
2026 Q2	$328K	Hold	47,462	–	–	0.16%	93
2026 Q1	$330K	Hold	47,462	–	–	0.16%	89
2025 Q4	$229K	Hold	47,462	–	–	0.12%	107
2025 Q3	$95.4K	Hold	47,462	–	–	0.05%	126
2025 Q2	$28.5K	Sell	47,462 -1,500	-3%	-$770	0.02%	114
2025 Q1	$13.2K	Hold	48,962	–	–	0.01%	117
2024 Q4	$25.5K	Sell	48,962 -30,000	-38%	-$73.2K	0.02%	101
2024 Q3	$256K	Buy	78,962 +100	+0.1%	+$324	0.17%	85
2024 Q2	$237K	Hold	78,862	–	–	0.17%	82
2024 Q1	$367K	Hold	78,862	–	–	0.26%	75
2023 Q4	$326K	Buy	78,862 +1,500	+2%	+$4.44K	0.25%	71
2023 Q3	$240K	Buy	77,362 +33	+0%	+$98	0.21%	74
2023 Q2	$220K	Hold	77,329	–	–	0.19%	76
2023 Q1	$175K	Hold	77,329	–	–	0.16%	79
2022 Q4	$270K	Sell	77,329 -30,000	-28%	-$263K	0.25%	71
2022 Q3	$3.97M	Buy	107,329 +73,995	+222%	+$2.05M	3.95%	2
2022 Q2	$633K	Sell	33,334 -600	-2%	-$13.1K	0.58%	46
2022 Q1	$885K	Hold	33,934	–	–	0.72%	43
2021 Q4	$765K	Buy	+33,934	New	+$755K	0.68%	52

Other funds holding RLMD

Parsons Capital Management Providence, Rhode Island $2.29B AUM 21.99% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

MGO One Seven Beachwood, Ohio $6.08B AUM 21.44% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

CV Advisors Aventura, Florida $594M AUM 18% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

American Capital Advisory Ketchum, Idaho $293M AUM 15.31% 1-Year Est. Return

Apricus Wealth's RLMD Position: Q3 2026 in Review

Apricus Wealth held its Relmada Therapeutics (RLMD) position steady in Q3 2026 at 47,462 shares worth $179K. The position accounts for 0.08% of the portfolio, ranked #128.

Apricus Wealth first reported a position in RLMD in Q4 2021 and has held it in 20 quarters since. The position peaked at $3.97M in Q3 2022. 16 funds tracked by Wall St. Rank hold RLMD as of Q3 2026.

Apricus Wealth held 47,462 shares of Relmada Therapeutics worth $179K as of Q3 2026.
Apricus Wealth left its Relmada Therapeutics share count unchanged in Q3 2026.
Relmada Therapeutics made up 0.08% of Apricus Wealth's portfolio in Q3 2026, its #128 holding.
Apricus Wealth first reported a position in Relmada Therapeutics in Q4 2021 and has held it in 20 quarters since.
Apricus Wealth's Relmada Therapeutics position peaked at $3.97M in Q3 2022.
16 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q3 2026.

Based on Apricus Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.